help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, F.
Right arrow Articles by Luo, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, F.
Right arrow Articles by Luo, J.-H.
(American Journal of Pathology. 2001;159:1603-1612.)
© 2001 American Society for Investigative Pathology

Short Communication

Myopodin, a Synaptopodin Homologue, Is Frequently Deleted in Invasive Prostate Cancers

Fan Lin*, Yan-Ping Yu*, Jeff Woods*, Kathleen Cieply*, Bill Gooding{dagger}, Patricia Finkelstein*, Rajiv Dhir*, Diane Krill*, Michael J. Becich*, George Michalopoulos*, Sydney Finkelstein* and Jian-Hua Luo*

From the Department of Pathology,*
School of Medicine, and the Biostatistic Center,{dagger}
University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

Prostate cancer is one of the leading causes of cancer-related deaths for men in the United States. Like other malignancies, prostate cancer is underscored by a variety of aberrant genetic alterations during its development. Although loss of heterozygosity or allelic loss is frequently identified among prostate cancers, few genes have been identified thus far as critical to the development of invasive prostate cancers. In this report, we used the recently developed technology, the "differential subtraction chain," to perform a genome-wide search for sequences that are deleted in an aggressive prostate cancer. Among the deleted sequences, we found that one sequence was deleted in >50% of prostate cancers we tested. We mapped this sequence to chromosome 4q25 by screening the Genebridge 4 hamster radiation panel with primers specific to this probe, and subsequently identify a 54-kb minimal common deletion region that contains the sequence encoding myopodin. Sequence analysis indicates that myopodin shares significant homology with synaptopodin, a protein closely associated with podocyte and neuron differentiation. Further study shows that frequent complete or partial deletions of the myopodin gene occurred among invasive prostate cancer cases (25 of 31 cases, or 80%). Statistical analysis indicates that deletion of myopodin is highly correlated with the invasiveness of prostate cancers, and thus may hold promise as an important prognostic marker for prostate cancers.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
Y. P. Yu and J.-H. Luo
Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin.
Cancer Res., August 1, 2006; 66(15): 7414 - 7419.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
Y. P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, et al.
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy
J. Clin. Oncol., July 15, 2004; 22(14): 2790 - 2799.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Jing, L. Liu, Y. P. Yu, R. Dhir, M. Acquafondada, D. Landsittel, K. Cieply, A. Wells, and J.-H. Luo
Expression of Myopodin Induces Suppression of Tumor Growth and Metastasis
Am. J. Pathol., May 1, 2004; 164(5): 1799 - 1806.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.